Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Prilocaine hydrochloride [USAN:USP]
RN: 1786-81-8
UNII: MJW015BAPH
InChIKey: BJPJNTKRKALCPP-UHFFFAOYSA-N

Note

  • A local anesthetic that is similar pharmacologically to LIDOCAINE. Currently, it is used most often for infiltration anesthesia in dentistry. (From AMA Drug Evaluations Annual, 1992, p165)

Molecular Formula

  • C13-H20-N2-O.Cl-H

Molecular Weight

  • 256.7749
 

Classification Codes

  • Anesthetic (Local)
  • Drug / Therapeutic Agent
  • Human Data
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Prilocaine hydrochloride [USAN:USP]

Synonyms

  • 2-(Propylamino)-o-propionotoluidide hydrochloride
  • 2-(Propylamino)-o-propionotoluidide monohydrochloride
  • alpha-Propylamine-2-methyl-propionanilide hydrochloride
  • Astra 1512
  • Citanest
  • Citanest hydrochloride
  • Citanest Plain
  • EINECS 217-244-0
  • L-67
  • Prilocaine chloride
  • Prilocaine HCl
  • Prilocaine hydrochloride
  • Propanamide, N-(2-methylphenyl)-2-(propylamino)-, monohydrochloride
  • Propitocaine hydrochloride
  • UNII-MJW015BAPH
  • Xylonest

Systematic Names

  • o-Propionotoluidide, 2-(propylamino)-, monohydrochloride
  • Prilocaine hydrochloride
  • Propanamide, N-(2-methylphenyl)-2-(propylamino)-, monohydrochloride

Mixture Name

  • Citanest forte

Registry Numbers

CAS Registry Number

  • 1786-81-8

FDA UNII

  • MJW015BAPH

System Generated Number

  • 0001786818

Molecular Formulas

Molecular Formula

  • C13-H20-N2-O.Cl-H

Molecular Formula Fragments

  • C13-H20-N2-O
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

InChI=1S/C13H20N2O.ClH/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2;/h5-8,11,14H,4,9H2,1-3H3,(H,15,16);1H

InChIKey

BJPJNTKRKALCPP-UHFFFAOYSA-N

Smiles

Cl.CCCNC(C)C(=O)Nc1ccccc1C

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man LDLo parenteral 12343ug/kg/1H (12.343mg/kg) BLOOD: HEMORRHAGE Journal of Analytical Toxicology. Vol. 10, Pg. 75, 1986.
mouse LD50 intraperitoneal 30mg/kg (30mg/kg)   "Handbook of Analytical Toxicology," Sunshine, I., ed., Cleveland, OH, Chemical Rubber Co., 1969Vol. -, Pg. 99, 1969.
mouse LD50 intravenous 55mg/kg (55mg/kg)   Drugs in Japan Vol. 6, Pg. 692, 1982.
mouse LD50 subcutaneous 632mg/kg (632mg/kg)   Drugs in Japan Vol. 6, Pg. 692, 1982.
rabbit LD50 intratracheal 65mg/kg (65mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)		 Journal of Pharmacology and Experimental Therapeutics. Vol. 132, Pg. 87, 1961.
rabbit LD50 intravenous 18mg/kg (18mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Journal of Pharmacology and Experimental Therapeutics. Vol. 132, Pg. 87, 1961.
rat LD50 intraperitoneal 148mg/kg (148mg/kg)   Drugs in Japan Vol. 6, Pg. 692, 1982.
rat LD50 intravenous 56600ug/kg (56.6mg/kg)   Drugs in Japan Vol. 6, Pg. 692, 1982.
rat LD50 subcutaneous 790mg/kg (790mg/kg)   Drugs in Japan Vol. 6, Pg. 692, 1982.